Bruker Corporation (BRKR) vs Haemonetics Corporation (HAE)
- Bruker Corporation BRKR 54.80 −3.08%
- Haemonetics Corporation HAE 118.28 −2.48%
Bruker Corporation and Haemonetics Corporation are both Medical Devices companies. Bruker Corporation is the larger, with a market value of $8.6B against $5.5B — 1.6× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; Haemonetics Corporation trades at 57.7×. Bruker Corporation grew revenue faster over the last twelve months: 1.65% against 0.44%. Haemonetics Corporation has the higher net margin (7.12% vs −3.05%) and the higher return on invested capital (5.62% vs −0.47%). Across the 21 metrics below, Haemonetics Corporation leads on 15 and Bruker Corporation on 6.
Valuation
Profitability
| Metric | BRKR | HAE | Medical Devices median |
|---|---|---|---|
| Gross margin | 46.42% | 59.03% | 56.01% |
| Operating margin | (0.87%) | 11.86% | (15.03%) |
| Net margin | (3.05%) | 7.12% | (20.40%) |
| Free cash flow margin | 2.68% | 21.64% | (7.24%) |
| Return on equity | (5.07%) | 11.20% | (15.32%) |
| Return on assets | (1.73%) | 3.99% | (19.72%) |
| Return on invested capital | (0.47%) | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack